Towards Buildingb Open Innovation Ecosystem in Poland: Challenges and Opportunities Cover Image

W kierunku otwartych ekosystemów innowacji w Polsce: szanse i wyzwania
Towards Buildingb Open Innovation Ecosystem in Poland: Challenges and Opportunities

Author(s): Małgorzata Runiewicz-Wardyn
Subject(s): Business Economy / Management, ICT Information and Communications Technologies
Published by: Szkoła Główna Handlowa w Warszawie
Keywords: open innovation; ecosystem; Quadruple helix; Poland, biopharma industry

Summary/Abstract: Nowadays rapidly changing businesses environment (with start-ups and predominance of big companies), shortening technological cycles and accelerating technological convergence raise the need to combine competences with others. An open innovation based Quadruple helix interlinkages ecosystem seems to be appropriate method to boost innovation capabilities in companies, sectors and the whole regions. The research paper aims to discuss the opportunities and challenges related to adapting open innovation models in Polish enterprises. The concept of open innovation and promotion of clusters are important elements of economic policy of the industrial competitiveness of Poland and Europe 2020 strategy. Yet, despite increasing expenditure on innovation in Polish enterprises, innovation collaboration among Triple Helix stakeholders as well as the role of clusters are not growing significantly. In 2016–2018, such collaboration was undertaken only by 36% of innovation-active industrial enterprises, over 40% of which were big companies. Moreover, the share of industrial enterprises collaborating under a cluster initiative in the total number of enterprises amounted only to 3.5%. One of the sectors, where innovative activity was most often undertaken biotech and pharmaceutical related industry (biopharma) (56.2%). The industry faces a high-cost of R&D, limited commercialization and constant technological change. Thus, there is a growing attention for open innovation and external partnership. The study shows that in Poland, open innovation collaboration within the biopharma industry is still in the infancy. Among the financial, legal, institutional barriers socio-cultural factors have had large effects on the behaviour of firms with respect to their engagement in open innovation practices.

  • Issue Year: 55/2020
  • Issue No: 2
  • Page Range: 15-27
  • Page Count: 13
  • Language: English